Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ACLY | P53396 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | HPGDS | O60760 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27561882 | 0.85 | LMNA (0.47) | LMNAACLYSRCCA12CA1 | |
| SCHEMBL27582572 | 0.82 | CA1 (0.46) | CA12CA1CA2CA9TSHR | |
| SCHEMBL7086849 | 0.80 | HDAC1 (0.46) | LMNACA12CA9ALDH1A1 | |
| SCHEMBL3217835 | 0.76 | HTT (0.51) | ALDH1A1CYP2C19CYP2D6 | |
| SCHEMBL3221517 | 0.74 | CYP2C19 (0.41) | LMNASRCCA12CA1CA9 | |
| SCHEMBL7573234 | 0.73 | NLRP3 (0.54) | — | |
| Acetic Acid SCHEMBL9574999 | 0.73 | ALDH1A1 (0.45) | LMNAACLYSRCALDH1A1CYP2C19 | |
| SCHEMBL7080942 | 0.73 | DUT (0.40) | LMNAACLYSRCCA12CA1 | |
| SCHEMBL6635997 | 0.72 | CYP2C19 (0.55) | LMNASRCALDH1A1CYP2C19CYP2D6 | |
| SCHEMBL4224462 | 0.72 | CYP2C19 (0.55) | ACLYSRCCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0592439-B1 | AMINOSULFONYL CARBAMATES | WARNER LAMBERT CO (US) | 2003-07-30 | — | — | EP | claimed |
| EP-0934303-B1 | COMPOUNDS USEFUL FOR INHIBITION OF FARNESYL PROTEIN TRANSFERASE | SCHERING CORP (US) | 2004-12-29 | — | — | EP | disclosed |
| EP-0927178-B1 | TRICYCLIC COMPOUNDS USEFUL FOR INHIBITION OF G-PROTEIN FUNCTION AND FOR TREATMENT OF PROLIFERATIVE DISEASES | SCHERING CORP (US) | 2002-02-27 | — | — | EP | disclosed |
| US-5958890-A | ANTITUMOR | SCHERING CORPORATION (US) | 1999-09-28 | — | — | US | disclosed |
| EP-0934303-A2 | COMPOUNDS USEFUL FOR INHIBITION OF FARNESYL PROTEIN TRANSFERASE | SCHERING CORPORATION (US) | 1999-08-11 | — | — | EP | disclosed |
| EP-0927178-A1 | TRICYCLIC COMPOUNDS USEFUL FOR INHIBITION OF G-PROTEIN FUNCTION AND FOR TREATMENT OF PROLIFERATIVE DISEASES | SCHERING CORPORATION (US) | 1999-07-07 | — | — | EP | disclosed |
| US-5861395-A | ENZYME INHIBITORS FOR BREAST TUMOR CELLS | SCHERING CORPORATION (US) | 1999-01-19 | — | — | US | disclosed |
| WO-1998011091-A2 | TRICYCLIC COMPOUNDS USEFUL FOR INHIBITION OF FARNESYL PROTEIN TRANSFERASE | SCHERING CORPORATION (US) | 1998-03-19 | — | — | WO | disclosed |
| WO-1998011096-A1 | TRICYCLIC COMPOUNDS USEFUL FOR INHIBITION OF G-PROTEIN FUNCTION AND FOR TREATMENT OF PROLIFERATIVE DISEASES | SCHERING CORPORATION (US) | 1998-03-19 | — | — | WO | disclosed |